--- title: "89 Biotech Investors in Europe (Nov 2026): Top 10 Ranked" last_updated: "2026-11-09" rows: "89" free_rows: "25" source: "SEC Form D filings and our own research" canonical: "https://theinvestordatabase.com/lists/biotech-investors-europe/" --- # 89 biotech investors in Europe We list 89 biotech investors in Europe as of November 2026: 1 has an SEC filing on file and 88 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The cities with the most head offices on this list are Paris (11), Stockholm (5) and Barcelona (4). - 89 investors - 45 with a fund filing or dated deal in the last 12 months - 306 named decision-makers on file ## First 25 of 89 biotech investors in Europe | Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile | |---|---|---|---|---|---|---|---|---| | M Ventures | Corporate VC | Amsterdam, Netherlands | | Biotech, Healthtech, AI, Deep Tech | Portfolio news, Oct 2026 | $27M (SEC Form ADV) | 2026-11-04 | https://theinvestordatabase.com/investors/m-ventures/ | | HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Biotech, Healthtech, Medtech | Portfolio news, Oct 2026 | $2.8B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hbm-partners-ag/ | | Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Biotech, Medtech, Healthtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/andera-partners/ | | Truffle Capital | VC firm | Paris, France | | Biotech, Healthtech, Medtech, Fintech | Portfolio news, Oct 2026 | €500M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/truffle-capital/ | | Fountain Healthcare Partners | VC firm | Dublin, Ireland | Seed | Biotech, Healthtech, Medtech | Portfolio news, Oct 2026 | €425M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/fountain-healthcare-partners/ | | NLC Health Ventures | VC firm | Amsterdam, Netherlands | Pre-seed, Seed | Biotech, Healthtech, Medtech | New fund, Sep 2026 | €300M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/nlc-fund-management-b-v/ | | Claris Ventures | VC firm | Turin, Italy | Pre-seed, Seed, Series A | Biotech, Healthtech | New fund, Oct 2026 | €190M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/claris-ventures-sgr/ | | Sofinnova Partners | VC firm | France (London office) | Seed, Series A, Series B, Growth | Biotech, Healthtech, Fintech, Agritech | New fund, Nov 2025 | €4.0B (own site) | 2026-11-05 | https://theinvestordatabase.com/investors/sofinnova-partners/ | | Hadean Ventures | VC firm | Norway | Seed, Series A, Series B | Biotech, Healthtech, Medtech | New deal, Sep 2026 | €230M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hadean-ventures-as/ | | Angelor | VC firm | Lyon, France | Seed, Series A | Biotech, Healthtech, Medtech, Food and Beverage | New deal, Sep 2026 | €100M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/angelor/ | | 819 Capital Partners | VC firm | Deventer, Netherlands | Seed, Series A, Growth | Biotech, Healthtech, Medtech, Generalist | Portfolio news, Sep 2026 | €100M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/819-capital-partners/ | | XISTA Science Ventures | VC firm | Klosterneuburg, Austria | Pre-seed, Seed | Biotech, Deep Tech, AI, Industrial Tech | Portfolio news, Oct 2026 | €96M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/xista-science-ventures-management-gmbh-2/ | | Biovance Capital | VC firm | Lisbon, Portugal | Seed, Series A | Biotech, Healthtech | New deal, Sep 2026 | €60M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/biovance-capital-partners-sociedade-de-capital-de-risco-s-a/ | | Wellington Partners | VC firm | Munich, Germany | Series A, Series B, Growth | Biotech, Healthtech, Medtech | Portfolio news, May 2026 | €210M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/wellington-partners/ | | CRB Health Tech | VC firm | Madrid, Spain | Seed, Series A | Biotech, Healthtech, Medtech | New fund, Oct 2026 | | 2026-11-07 | https://theinvestordatabase.com/investors/crb-health-tech-s-g-e-i-c-s-a/ | | Industrifonden | VC firm | Stockholm, Sweden | Seed, Series A, Series B, Growth | Biotech, Healthtech, Deep Tech, Climate Tech | Portfolio news, Oct 2026 | | 2026-11-07 | https://theinvestordatabase.com/investors/industrifonden/ | | TVM Capital Life Science | VC firm | Munich, Germany | Seed, Series A, Series B, Growth | Biotech, Healthtech, Medtech | Portfolio news, Sep 2026 | | 2026-11-07 | https://theinvestordatabase.com/investors/tvm-capital-life-science/ | | BioGeneration Ventures | VC firm | Naarden, Netherlands | Seed, Series A | Biotech, Healthtech | Portfolio news, Sep 2026 | | 2026-11-07 | https://theinvestordatabase.com/investors/biogeneration-ventures/ | | Gimv | Fund manager | Antwerp, Belgium | Growth, Late stage | Biotech, Healthtech, Consumer, Industrial Tech | Portfolio news, Sep 2026 | | 2026-11-07 | https://theinvestordatabase.com/investors/gimv/ | | Gilde Healthcare | Fund manager | Utrecht, Netherlands | Series A, Series B, Growth | Biotech, Healthtech, Medtech, Climate Tech | New fund, Feb 2026 | €3.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/gilde-healthcare-partners-b-v/ | | Seventure Partners | VC firm | Paris, France | | Biotech, Healthtech, Food and Beverage, Generalist | Portfolio news, Nov 2026 | | 2026-11-07 | https://theinvestordatabase.com/investors/seventure-partners/ | | XGEN Venture | VC firm | Milan, Italy | Seed, Series A | Biotech, Healthtech, Medtech | Portfolio news, Oct 2026 | | 2026-11-07 | https://theinvestordatabase.com/investors/xgen-venture-sgr-spa/ | | SHS Capital | Fund manager | Tübingen, Germany | Growth | Biotech, Healthtech, Medtech | New fund, Feb 2026 | €270M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/shs-gesellschaft-fur-beteiligungsmanagement-mbh/ | | Pureos Bioventures | VC firm | Switzerland | | Biotech, Healthtech | Portfolio news, Oct 2026 | | 2026-11-07 | https://theinvestordatabase.com/investors/pureos-partners/ | | Mérieux Equity Partners | Fund manager | Lyon, France | Seed, Series A, Series B | Biotech, Healthtech, Medtech | Investment listed in 2026 | €150M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/merieux-equity-partners/ | You are seeing 25 of 89. The full list adds 64 more investors and 306 named decision-makers. Get all 89 investors and 306 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/biotech-investors-europe This page: https://theinvestordatabase.com/lists/biotech-investors-europe/ ## Method and limits - Source: 1 of the 89 rows carries an SEC filing (Form D or Form ADV). All 89 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research. - Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio. - Order: Activity score out of 100: recency of the latest fund filing or dated deal (40: within 3 months 40, 6 months 30, 12 months 20, 24 months 10), share of the observed portfolio in this sector (30; 15 when the sector is stated only), size of the fund on file on a log scale (20) and completeness of the public record (10). It is a measure of activity and fit, not of quality or returns. - Fill rates: Of 89 rows: stage 79, sector 89, fund size 37, website 89. In the paid file: named decision-makers on 77 rows, firm email on 63, LinkedIn page on 70, check size on 30. ## Questions ### How many biotech investors in Europe are there? We list 89 as of November 2026. 45 of the 89 have a fund filing or a dated deal in the last 12 months. The cities with the most are Paris (11), Stockholm (5) and Barcelona (4). ### Which biotech investors in Europe raised a new fund in the last 12 months? 2 of the 89 have a fund filing dated in the last 12 months: Claris Ventures (Oct 2026) and Ysios Capital (Mar 2026). 45 of the 89 have a fund filing or a dated deal in that time. ### What is the typical fund size of biotech investors in Europe? None of the 89 discloses a fund size on an SEC Form D, so there is no median to give. 37 rows carry a size or assets figure from another public source, for example M Ventures at $27M (SEC Form ADV) and HBM Partners at $2.8B (own site). ### Which stage do most biotech investors in Europe back? Of the 79 with a stage on file, seed (65), Series A (55) and growth-stage (31). A firm can back more than one stage, and 10 rows have no stage on file yet. ### Where does the data on biotech investors in Europe come from and how often is it updated? 1 of the 89 rows has an SEC filing on file (Form D or Form ADV) and 88 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year. ### Can I download the list of biotech investors in Europe as a spreadsheet? Yes. The file holds all 89 rows in Excel and CSV, with 306 named decision-makers and 63 firm emails, for $49 one-time. 25 rows are free on this page.